Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1984 1
1986 2
1988 1
1989 1
1990 3
1991 4
1992 1
1994 1
1996 2
1997 2
1998 10
1999 7
2000 8
2001 17
2002 35
2003 41
2004 55
2005 52
2006 50
2007 44
2008 61
2009 52
2010 60
2011 56
2012 75
2013 88
2014 89
2015 141
2016 164
2017 210
2018 174
2019 132
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,417 results
Results by year
Filters applied: . Clear all
Page 1
American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States.
Mahmoudjafari Z, Hawks KG, Hsieh AA, Plesca D, Gatwood KS, Culos KA. Mahmoudjafari Z, et al. Biol Blood Marrow Transplant. 2019 Jan;25(1):26-33. doi: 10.1016/j.bbmt.2018.09.024. Epub 2018 Sep 26. Biol Blood Marrow Transplant. 2019. PMID: 30266675 Free article.
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.
Ruella M, Barrett DM, Kenderian SS, Shestova O, Hofmann TJ, Perazzelli J, Klichinsky M, Aikawa V, Nazimuddin F, Kozlowski M, Scholler J, Lacey SF, Melenhorst JJ, Morrissette JJ, Christian DA, Hunter CA, Kalos M, Porter DL, June CH, Grupp SA, Gill S. Ruella M, et al. J Clin Invest. 2016 Oct 3;126(10):3814-3826. doi: 10.1172/JCI87366. Epub 2016 Aug 29. J Clin Invest. 2016. PMID: 27571406 Free PMC article.
Neurotoxicity after CTL019 in a pediatric and young adult cohort.
Gofshteyn JS, Shaw PA, Teachey DT, Grupp SA, Maude S, Banwell B, Chen F, Lacey SF, Melenhorst JJ, Edmonson MJ, Panzer J, Barrett DM, McGuire JL. Gofshteyn JS, et al. Ann Neurol. 2018 Oct;84(4):537-546. doi: 10.1002/ana.25315. Epub 2018 Sep 26. Ann Neurol. 2018. PMID: 30178481 Free PMC article. Clinical Trial.
A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML.
John S, Chen H, Deng M, Gui X, Wu G, Chen W, Li Z, Zhang N, An Z, Zhang CC. John S, et al. Mol Ther. 2018 Oct 3;26(10):2487-2495. doi: 10.1016/j.ymthe.2018.08.001. Epub 2018 Aug 7. Mol Ther. 2018. PMID: 30131301 Free PMC article.
Safety of 5914 intravitreal ziv-aflibercept injections.
Singh SR, Stewart MW, Chattannavar G, Ashraf M, Souka A, ElDardeery M, Wadhwa N, Sarvaiya C, Mansour AM, Marashi A, Ramchandani S, Braimah IZ, Jabbarpoor Bonyadi MH, Ramezani A, Soheilian M, de Oliveira Dias JR, de Andrade GC, Maia A, Rodrigues EB, Farah ME, Banker A, Chhablani J; Ziv-aflibercept Study Group. Singh SR, et al. Br J Ophthalmol. 2019 Jun;103(6):805-810. doi: 10.1136/bjophthalmol-2018-312453. Epub 2018 Aug 11. Br J Ophthalmol. 2019. PMID: 30099379 Clinical Trial.
1,417 results
Jump to page
Feedback